Arkolith/Insider Trading/FHTX/Form 4

Gottschalk Adrian

Chief Executive Officer, DirectorFoghorn Therapeutics Inc. (FHTX) · full profile →Form 4 · filed Feb 22, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 17, 2023Gift(G)4K—$063K
Feb 17, 2023Other(J)185K—$0449K
Feb 17, 2023Gift(G)4K—$0449K
Feb 17, 2023Other(J)185K—$0449K
Oct 25, 2022Other(J)4K—$0444K
Oct 25, 2022Other(J)4K—$067K
Feb 10, 2022Gift(G)123K—$0449K
Feb 10, 2022Gift(G)123K—$023K

Transaction Codes

G
Gift
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-23-001675) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML